Carmen Schade-Brittinger

TL;DR: In this six-month study of patients under 75 years of age with severe motor complications of Parkinson's disease, neurostimulation of the subthalamic nucleus was more effective than medical management alone.

TL;DR: Octreotide LAR demonstrates substantial tumor control and shows a more favorable antiproliferative response than placebo as two-thirds of patients treated with octreotide ARL achieved stable disease at 6 mos, and patients treatment-naïve patients with histologically confirmed locally inoperable or metastasized well-differentiated NETs had a 66% risk reduction of tumor progression.

TL;DR: Subthalamic stimulation was superior to medical therapy in patients with Parkinson's disease and early motor complications and time with good mobility and no dyskinesia.

TL;DR: Low back pain improved after acupuncture treatment for at least 6 months and effectiveness of acupuncture, either verum or sham, was almost twice that of conventional therapy.

TL;DR: Rates of response and progression-free survival were significantly better with EDP plus mitotane than with streptozocin plus Mitotane as first-line therapy, with similar rates of toxic events, although there was no significant difference in overall survival.